Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk

BACKGROUND AND PURPOSE: The optimal stereotactic ablative radiotherapy (SABR) doses for adrenal tumors are unknown. Some trials have specified that organ at risk (OAR) dose constraints should take priority over target coverage. We performed a retrospective review of the outcomes of MR-guided adrenal...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneiders, Famke L., van Vliet, Claire, Giraud, Nicolas, Bruynzeel, Anna M.E., Slotman, Ben J., Palacios, Miguel A., Senan, Suresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551830/
https://www.ncbi.nlm.nih.gov/pubmed/37808454
http://dx.doi.org/10.1016/j.ctro.2023.100680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551830/
https://www.ncbi.nlm.nih.gov/pubmed/37808454
http://dx.doi.org/10.1016/j.ctro.2023.100680

Ejemplares similares